How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […] …read more […]
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on March 25th after seeing unprecedented fiscal and monetary stimulus unleashed by the Fed and the Congress. […] …read more […]
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […] …read more […]
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […] …read more […]
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […] …read more […]
Robinhood traders aren’t the only ones buying Tesla’s stock, contends one of the electric car maker’s biggest bulls. …read more […]
The rapid push toward a coronavirus vaccine is feed concerns among health experts, who fear the COVID-19 crisis response will be further polarized and undermined by political pressures. …read more […]
Nestlé paid $2.6 billion to gain ownership of Aimmune Treatment. Yahoo Finance’s On The Move panel share the details. …read more […]
(Bloomberg) — Robinhood Markets, Charles Schwab Corp. and other online brokerages grappled with trading and other technical problems Monday, leaving customers venting their frustrations online.TD Ameritrade Holding Corp. and Vanguard Group also were among companies that said they were working to resolve delays in order updates and trouble accessing websites, among other disruptions. Thousands of customers lodged complaints on Downdetector.Robinhood, which reported problems related to equities, options and cryptocurrency trading, said shortly after noon in New York that it had resolved them.“We apologize for the inconvenience,” the company said in an emailed statement.While online brokerages routinely experience brief outages, it’s …read more […]
(Bloomberg) — Robinhood Markets has catapulted ahead of its online brokerage rivals with a smartphone app that has attracted an army of young investors. Yet with the company’s rise has come a litany of problems: trading outages, angry customers and regulatory probes.Over the first half of the year, U.S. consumer protection agencies received more than 400 complaints about Robinhood — roughly four times more than competitors like Charles Schwab Corp. and Fidelity Investments’ brokerage unit. The grievances, obtained via a public records request to the Federal Trade Commission, depict novice investors in over their heads, struggling to understand why they’ve …read more […]
Lookout below for stocks? Yes, if history is any guide. …read more […]
The coronavirus has thrust many previously unknown pharma companies into the spotlight. You can certainly place Sorrento Therapeutics (SRNE) on this list. The company’s unique approach to fighting COVID-19 has resulted in sky scraping surges, yet it hasn’t all been plain sailing. The Yale School of Public has recently won an FDA emergency approval for its saliva-based diagnostic test, which puts it ahead of Sorrento’s COVI-TRACE. Adding more fuel to fire, Sorrento announced the ousting of its chief financial officer. In reaction, investors got cold feet, sending shares tumbling nearly 35% in the past two weeks. Sorrento’s playbook for fighting …read more […]
(Bloomberg) — Elon Musk is the third-richest person in the world — at least for the moment.Musk passed Facebook Inc. co-founder Mark Zuckerberg Monday as shares of Tesla Inc. continued their unrelenting rally after undergoing a forward stock split. As of 11:25 a.m., Musk was worth $111.3 billion compared with $110.5 billion for Zuckerberg, according to the Bloomberg Billionaires Index, which is updated at the end of each market day.Musk has seen a meteoric rise in his wealth, with his net worth growing by $76.1 billion this year as Tesla shares surged more than 475%. Also helpful: an audacious pay …read more […]
Growth stocks are commonly known as an investors’ delight. Who doesn’t want to invest in a company that is growing faster than the market average? However, these stocks come with more risk than you may imagine.
Oversized gains are usually a sign of good things to come. Yet, most of these companies don’t offer dividends and their share price is largely based on expectations. Let’s take a deeper look below.
What Are Growth Stocks?
Companies on the rise can make all the difference with your investment portfolio. So, what are growth stocks exactly? These are shares of companies that expect to increase revenue …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
